The global vaccine market size was estimated at USD 72.75 billion in 2025 and is projected to reach USD 115.77 billion by 2033, growing at a CAGR of 5.78% from 2026 to 2033. The market is driven by the increasing investment in R&D and the rising focus of sponsors & investigators ... Read More »
January 2026The global high potency active pharmaceutical ingredients (HPAPI) market size was estimated at USD 29.87 billion in 2025 and is projected to reach USD 48.29 billion by 2033, growing at a CAGR of 6.2% from 2026 to 2033. This growth is primarily driven by the rising prevalence of cancer an... Read More »
January 2026The global cancer vaccine market size was estimated at USD 9.93 billion in 2025 and is projected to reach USD 23.31 billion by 2033, growing at a CAGR of 11.30% from 2026 to 2033. This growth is primarily driven by the rising global burden of cancer, increasing adoption of immunotherapy-... Read More »
January 2026The global meningococcal vaccines market size was estimated at USD 4.05 billion in 2025 and is projected to reach USD 5.96 billion by 2033, growing at a CAGR of 4.5% from 2026 to 2033. The increasing prevalence of meningitis is one of the major factors expected to drive the market. Accor... Read More »
January 2026The global human growth hormone market size was estimated at USD 7.52 billion in 2025 and is projected to reach USD 28.41 billion by 2040, growing at a CAGR of 8.52% from 2026 to 2040. The main reason for the high demand of human growth hormone is adult hormone deficiency, especially Gro... Read More »
January 2026The global generic pharmaceuticals market size was estimated at USD 454.7 billion in 2025 and is projected to reach USD 770.0 billion by 2033, growing at a CAGR of 6.5% from 2026 to 2033. The growth can be attributed to the constant increase in the number of ANDA approvals and generic dr... Read More »
January 2026The U.S. complementary and alternative medicine market size was estimated at USD 52.78 billion in 2025 and is projected to reach USD 375.51 billion by 2033, growing at a CAGR of 27.8% from 2026 to 2033. The market growth can be attributed to the increasing prevalence of chronic diseases,... Read More »
January 2026The global brachytherapy market size was estimated at USD 1,112.97 million in 2025 and is projected to reach USD 1,967.19 million by 2033, growing at a CAGR of 7.4% from 2026 to 2033. The increasing prevalence of cancer, technological advancements, and a significant rise in the adoption ... Read More »
January 2026The global complementary and alternative medicine market size was estimated at USD 222.62 billion in 2025 and is projected to reach USD 1,430.70 billion by 2033, growing at a CAGR of 26.4% from 2026 to 2033. Growing awareness regarding complementary and alternative medicine (CAM), increa... Read More »
January 2026The global nutritional supplements market size was estimated at USD 517.09 billion in 2025 and is projected to reach USD 862.51 billion by 2033, growing at a CAGR of 6.62% from 2026 to 2033. Market growth is driven by rising health awareness, increasing demand for preventive healthcare, ... Read More »
January 2026The global anti-aging supplements market was valued at USD 4.78 billion in 2025 and is anticipated to reach USD 9.06 billion by 2033, growing at a CAGR of 8.49% from 2026 to 2033. The market for anti-aging supplements has grown significantly due to factors such as rising consumer awarene... Read More »
January 2026The global branded generics market size was estimated at USD 276.98 billion in 2025 and is projected to reach USD 453.05 billion by 2033, growing at a CAGR of 6.5% from 2026 to 2033. The market continues to be shaped by strong demand in emerging economies, where prescription behavior fav... Read More »
January 2026The global biosimilars market size was estimated at USD 39.59 billion in 2025 and is projected to reach USD 151.58 billion by 2033, growing at a CAGR of 18.44% from 2026 to 2033. The cost-effectiveness of biosimilar drugs and the prevalence of chronic disorders globally are major factors... Read More »
January 2026The global radiotheranostics market size was estimated at USD 11.79 billion in 2025 and is projected to reach USD 25.56 billion by 2033, growing at a CAGR of 9.5% from 2026 to 2033. The market represents a precision medicine approach that integrates molecular imaging with targeted radion... Read More »
January 2026The global glioblastoma multiforme treatment market size was estimated at USD 4.04 billion in 2025 and is projected to reach USD 7.87 billion by 2033, growing at a CAGR of 8.69% from 2026 to 2033. The rising prevalence of Glioblastoma Multiforme (GBM) and its significant clinical burden ... Read More »
January 2026The global vaccine adjuvants market size was estimated at USD 3.94 billion in 2025 and is projected to reach USD 5.96 billion by 2033, growing at a CAGR of 5.60% from 2026 to 2033. The growth of the market is driven by the increasing demand for effective vaccines to combat emerging and r... Read More »
January 2026The global immunotherapy drugs market size was estimated at USD 285.73 billion in 2025 and is expected to reach USD 675.98 billion by 2033, growing at a CAGR of 11.41% from 2026 to 2033. This market is primarily driven by the rising incidence of chronic diseases globally. This market was... Read More »
January 2026The global osteoarthritis therapeutics market size was estimated at USD 5.49 billion in 2025 and is projected to reach USD 10.89 billion by 2033, growing at a CAGR of 8.88% from 2026 to 2033. The osteoarthritis (OA) treatment market is witnessing significant growth, driven by the increas... Read More »
January 2026The global drug discovery outsourcing market size was estimated at USD 8.08 billion in 2025 and is projected to reach USD 17.11 billion by 2033, growing at a CAGR of 10.0% from 2026 to 2033. The market growth is driven by increasing drug development activities, the growing complexity of ... Read More »
January 2026The global biopharmaceutical excipients market size was estimated at USD 3.18 billion in 2025 and is projected to reach USD 4.97 billion by 2033, growing at a CAGR of 5.79% from 2026 to 2033. The industry is growing due to the rapid expansion of biologic drugs such as monoclonal antibodi... Read More »
January 2026